SLU-PP-332 Reconstitution Chart (Every Vial Size)

Overview of SLU-PP-332 and Laboratory Reconstitution Fundamentals

SLU-PP-332 is a synthetic small-molecule Estrogen-Related Receptor alpha (ERRα) agonist frequently investigated in preclinical metabolic and bioenergetic assays. Supplied as a lyophilized powder or high-purity crystalline solid, preparing this compound for laboratory assays requires precise volumetric reconstitution to establish exact target concentrations (mg/mL or µg/µL). Accurately calculating final concentration and aliquot volumes is crucial for maintaining experimental reproducibility across cellular models and animal tissue preparations.

When preparing research compounds, researchers must systematically control solvent volume, ambient temperature, and mechanical agitation to prevent degradation or precipitate formation. Utilizing a standard slu-pp-332 reconstitution chart simplifies daily laboratory calculations, minimizing human error when loading microplates or formulating parenteral formulations for preclinical models. PX1 Research supplies high-purity research materials accompanied by batch-specific documentation to support consistent laboratory outcomes.

Mathematical Reconstitution Formula and Dilution Equations

Determining the target concentration ($C$) of a reconstituted SLU-PP-332 solution relies on a straightforward volumetric equation derived from basic mass-concentration principles:

$$\text{Concentration (mg/mL)} = \frac{\text{Total Vial Mass (mg)}}{\text{Added Diluent Volume (mL)}}$$

To calculate the total mass contained within a specific aliquot volume (for instance, a standard $0.1\text{ mL}$ or $100\text{ µL}$ micro-dispense), researchers apply the following formula:

$$\text{Mass per 0.1 mL (mg)} = \text{Concentration (mg/mL)} \times 0.1\text{ mL}$$

For complex serial dilutions or when working with automated fluid handlers, investigators can cross-reference calculations using our interactive reconstitution calculator or consult the comprehensive reference catalog in our all peptides hub.

SLU-PP-332 Reconstitution Chart (Standard Lab Vial Masses)

The following master reference table details resulting concentrations ($mg/mL$) and delivered mass per $0.1\text{ mL}$ ($100\text{ µL}$) aliquot across standard laboratory vial sizes ($2\text{ mg}$, $5\text{ mg}$, and $10\text{ mg}$) when mixed with varying volumes of laboratory solvent.

| Vial Mass | Diluent Volume (mL) | Resulting Concentration (mg/mL) | Mass per 0.1 mL (100 µL) | Mass per 0.05 mL (50 µL) | | :--- | :--- | :--- | :--- | :--- | | **2 mg** | 1.0 mL | 2.0 mg/mL | 0.20 mg (200 µg) | 0.10 mg (100 µg) | | **2 mg** | 2.0 mL | 1.0 mg/mL | 0.10 mg (100 µg) | 0.05 mg (50 µg) | | **2 mg** | 4.0 mL | 0.5 mg/mL | 0.05 mg (50 µg) | 0.025 mg (25 µg) | | **5 mg** | 1.0 mL | 5.0 mg/mL | 0.50 mg (500 µg) | 0.25 mg (250 µg) | | **5 mg** | 2.5 mL | 2.0 mg/mL | 0.20 mg (200 µg) | 0.10 mg (100 µg) | | **5 mg** | 5.0 mL | 1.0 mg/mL | 0.10 mg (100 µg) | 0.05 mg (50 µg) | | **10 mg** | 2.0 mL | 5.0 mg/mL | 0.50 mg (500 µg) | 0.25 mg (250 µg) | | **10 mg** | 5.0 mL | 2.0 mg/mL | 0.20 mg (200 µg) | 0.10 mg (100 µg) | | **10 mg** | 10.0 mL | 1.0 mg/mL | 0.10 mg (100 µg) | 0.05 mg (50 µg) |

Researchers conducting benchtop assays should ensure pipettes are calibrated to ISO 8655 standards when measuring diluent volumes. To review physical pre-formulated solid options, examine the SLU-PP-332 capsule specification.

Step-by-Step Worked Reconstitution Calculations

**Worked Example 1: Standard 5 mg Vial Dilution** An investigator aims to prepare a $2.0\text{ mg/mL}$ stock solution from a lyophilized vial containing $5\text{ mg}$ of pure SLU-PP-332. Applying the primary concentration equation: $$\text{Diluent Volume} = \frac{\text{Mass}}{\text{Target Concentration}} = \frac{5\text{ mg}}{2.0\text{ mg/mL}} = 2.5\text{ mL}$$ By introducing $2.5\text{ mL}$ of appropriate solvent (e.g., bacteriostatic water or target-compatible vehicle), each $0.1\text{ mL}$ aliquot will yield exactly $0.2\text{ mg}$ ($200\text{ µg}$) of active compound.

**Worked Example 2: High-Concentration 10 mg Preparation** A research lab requires a concentrated $5.0\text{ mg/mL}$ stock solution using a $10\text{ mg}$ vial of SLU-PP-332. Calculating the required diluent volume yields: $$\text{Diluent Volume} = \frac{10\text{ mg}}{5.0\text{ mg/mL}} = 2.0\text{ mL}$$ Adding $2.0\text{ mL}$ of solvent creates a $5.0\text{ mg/mL}$ solution, providing $0.5\text{ mg}$ ($500\text{ µg}$) per $0.1\text{ mL}$ micro-dispense volume. For additional concentration protocols across other metabolic modulators, visit our expanded research library hub.

Solubility Profile, Solvent Selection, and Reconstitution Reagents

Selecting the correct solvent is critical when reconstituting hydrophobic or amphipathic research compounds. Depending on the planned assay platform—whether cell culture assays or *in vivo* rodent models—investigators may choose between aqueous diluents and organic co-solvents:

1. **Bacteriostatic Water (0.9% Benzyl Alcohol):** Suitable for sterile multi-dose vial sampling in preclinical models, inhibiting microbial growth over extended storage periods. 2. **Sterile Water for Injection (SWFI):** Ideal for immediate, single-use *in vitro* applications where preservative agents might interfere with cell line viability. 3. **DMSO / PEG-400 Co-Solvent Systems:** For high-concentration stock formulations where organic solubilization is necessary prior to downstream dilution into aqueous cell culture media.

Always allow the vial and solvent to reach room temperature prior to mixing. Direct liquid streams against the glass wall of the vial rather than splashing directly onto the lyophilized cake. Gently swirl the vial until the solid is completely dissolved; avoid vigorous vortexing, which can cause shearing or foaming.

Preclinical Target Mechanisms and Comparative Metabolic Compounds

Preclinical studies indicate that SLU-PP-332 functions as a potent, selective agonist of Estrogen-Related Receptor alpha (ERRα). ERRα is an orphan nuclear receptor that regulates transcriptional networks responsible for mitochondrial biogenesis, oxidative phosphorylation, and fatty acid oxidation in metabolic tissues such as skeletal muscle and cardiac tissue. *In vitro* assays demonstrate that activation of ERRα upregulates key metabolic genes including PGC-1α targets, enhancing cellular respiration without requiring physical exercise stimulation.

In metabolic research clusters, investigators frequently evaluate SLU-PP-332 alongside comparable mitochondrial and exercise-mimetic research compounds. For example, compounds such as the PPARδ agonist GW501516, the Rev-Erbα agonist SR9009, and the mitochondrial-derived peptide MOTS-c are routinely evaluated in parallel assays to compare their distinct signaling cascades, oxidative endurance effects, and cellular energy expenditures.

Handling, Storage, and Solution Stability Parameters

Lyophilized SLU-PP-332 should be stored at $-20^\circ\text{C}$ to $-80^\circ\text{C}$ in a dry environment protected from direct light. Under these conditions, the unconstituted dry powder remains stable for up to 24 months. Researchers should consult the batch-specific chemical analysis provided on our certificate of analysis page to verify shelf-life and stability profiles.

Once reconstituted into aqueous solution, storage parameters change substantially:

- **Refrigerated Storage ($2^\circ\text{C}$ to $8^\circ\text{C}$):** Reconstituted solutions using bacteriostatic water maintain chemical integrity for up to 28 days. - **Frozen Stock Aliquots ($-20^\circ\text{C}$ to $-80^\circ\text{C}$):** For long-term storage, reconstitute in pure solvent, divide into single-use micro-aliquots, and freeze immediately. Avoid repeated freeze-thaw cycles, which accelerate chemical degradation.

For large-scale research projects requiring consistent material lots, laboratories can arrange custom supply terms through our wholesale lab account portal.

Quality Verification, HPLC/MS Purity, and Endotoxin Standards

PX1 Research enforces strict quality control standards for all analytical and research-grade compounds. Every batch of SLU-PP-332 undergoes rigorous verification inside an ISO 17025 accredited testing facility using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). This process verifies identity, chemical structure, and guarantees a purity rating of $\ge 99\%$.

Additionally, compounds undergo chromogenic LAL assays to confirm endotoxin levels remain below strictly controlled thresholds ($< 0.01\text{ EU/mg}$), preventing confounding inflammatory responses in sensitive cell lines or rodent assays. All PX1 products are manufactured in GMP-compliant facilities within the USA and shipped direct from fulfillment centers in California and Arizona with same-day dispatch for orders placed Monday through Friday.

Advanced Laboratory Protocols for Assay Microdilutions

When preparing serial microdilutions for cell-based microplate assays (e.g., 96-well or 384-well plates), starting from an accurate stock solution is essential. Researchers should establish a primary stock at $10\text{ mM}$ or $1\text{ mg/mL}$ in analytical-grade DMSO, followed by step-down dilutions into physiological buffers like phosphate-buffered saline (PBS) or serum-free culture medium.

To minimize compound adsorption to plasticware, utilize low-retention polypropylene microcentrifuge tubes and pipette tips. Detailed protocols on receptor binding kinetics and structural biology can be explored further in our specialized guide on SLU-PP-332 mechanism of action.